Revance Therapeutics Market Cap

IST:ERSU has a market cap or net worth of 610.20 million as of August 1, 2025. Its market cap has decreased by -10.98% in one year.

Market Cap

610.20M

Enterprise Value

537.99M

Revenue

106.51M

Ranking

n/a

PE Ratio

n/a

Stock Price

$17.20

Market Cap Chart

Since March 1, 2007, IST:ERSU's market cap has increased from 47.88M to 610.20M, an increase of 1,174.44%. That is a compound annual growth rate of 14.81%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	610.20M	-3.80%
Dec 31, 2024	634.32M	53.75%
Dec 29, 2023	412.56M	83.95%
Dec 30, 2022	224.28M	0.81%
Dec 31, 2021	222.48M	25.10%
Dec 31, 2020	177.84M	138.65%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BIM Birlesik Magazalar A.S.	305.66B
Kent Gida Maddeleri Sanayii ve Ticaret A.S.	167.42B
Coca-Cola Içecek Anonim Sirketi	140.32B
Migros Ticaret A.S.	95.69B
Anadolu Efes Biracilik ve Malt Sanayii Anonim Sirketi	90.71B
GRAINTURK Holding A.S.	57.81B
Türk Tuborg Bira ve Malt Sanayii A.S.	54.57B
Efor Cay Sanayi Ticaret Anonim Sirketi	50.60B

Market Cap Rankings